ARTICLE | Clinical News
Welchol colesevelam regulatory update
August 1, 2011 7:00 AM UTC
FDA approved an sNDA from Daiichi for an oral suspension formulation of Welchol colesevelam to be mixed with fruit juice or diet soft drinks to reduce elevated low-density lipoprotein cholesterol (LDL...